These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 694842)

  • 1. Anticoagulant effects of autoprothrombin II-A and prothrombin fragment 1.
    Seegers WH; Marlar RA; Walz DA
    Thromb Res; 1978 Aug; 13(2):233-43. PubMed ID: 694842
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thrombin and autoprothrombin C (F-X a ) as a mutual depletion system.
    Dombrose FA; Seegers WH; Sedensky JA
    Thromb Diath Haemorrh; 1971 Aug; 26(1):103-23. PubMed ID: 5112369
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of blood clotting factor V in the conversion of prothrombin and a decarboxy prothrombin into thrombin.
    Vermeer C; Govers-Riemslag JW; Soute BA; Lindhout MJ; Kop J; Hemker HC
    Biochim Biophys Acta; 1978 Feb; 538(3):521-33. PubMed ID: 564211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A variant of prothrombin induced in cattle by prolonged administration of warfarin.
    Prowse CV; Mattock P; Esnouf MP; Russell AM
    Biochim Biophys Acta; 1976 May; 434(1):265-79. PubMed ID: 938668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of autoprothrombin C in the reactions of the body's anticoagulant system].
    Suchkova SN; Strukova SM; Baskova IP; Kudriashov BA
    Vopr Med Khim; 1970; 16(4):409-15. PubMed ID: 5509905
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 8. The coagulation of blood: preliminary survey of thrombin and autoprothrombin zymogen structure.
    Seegers WH; Murano G; McCoy L; Marciniak E
    Life Sci; 1969 Sep; 8(18):925-32. PubMed ID: 5346943
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved procedures for the purification of selected vitamin K-dependent proteins.
    Novoa E; Seegers WH; Hassouna HI
    Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of autoprothrombin 3rd to autoprothrombin C in sodium citrate solution.
    Kipper R; Seegers WH
    Thromb Diath Haemorrh; 1968 Mar; 19(1):204-12. PubMed ID: 5652227
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prothrombin activation mechanism].
    Sakuragawa N
    Nihon Rinsho; 1974 May; 32(5):901-9. PubMed ID: 4603779
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of alpha-thrombin and beta-thrombin-E formation: use of ecarin for isolation of meizothrombin 1.
    Novoa E; Seegers WH
    Thromb Res; 1980 Jun; 18(5):657-68. PubMed ID: 6998042
    [No Abstract]   [Full Text] [Related]  

  • 13. Intermediates of prothrombin activation.
    Mann KG; Bajaj SP; Heldebrant CM; Butkowski RJ; Fass DN
    Ser Haematol; 1973; 6(4):479-93. PubMed ID: 4794965
    [No Abstract]   [Full Text] [Related]  

  • 14. [The action of factor 8 (antihemophilic globulin) on the consumption of factor X during coagulation].
    Mayer G; Mayer S; Waitz R
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):287-95. PubMed ID: 5584959
    [No Abstract]   [Full Text] [Related]  

  • 15. Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipids.
    Freyssinet JM; Beretz A; Klein-Soyer C; Gauchy J; Schuhler S; Cazenave JP
    Biochem J; 1988 Dec; 256(2):501-7. PubMed ID: 2851994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady state relations between factors X, Xa, II, IIa, antithrombin III and alpha-2 macroglobulin in thrombosis.
    Reeve EB
    Thromb Res; 1980 Apr 1-15; 18(1-2):19-31. PubMed ID: 6157218
    [No Abstract]   [Full Text] [Related]  

  • 17. Postclotting fates of thrombin.
    Seegers WH
    Semin Thromb Hemost; 1986 Jul; 12(3):181-3. PubMed ID: 3775386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An hepatic inhibitor of activated clotting factor X (Stuart).
    Deykin D; Cochios F; Mosher D
    Biochem Biophys Res Commun; 1969 Jan; 34(2):245-51. PubMed ID: 5796744
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicity of blood clotting factors.
    MARCINIAK E; RODRIGUEZ-ERDMANN F; SEEGERS WH
    Science; 1962 Aug; 137(3528):421-2. PubMed ID: 14469665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal activation of a human prothrombin variant: prothrombin Barcelona.
    Rabiet MJ; Benarous R; Labie D; Josso F
    FEBS Lett; 1978 Mar; 87(1):132-4. PubMed ID: 631326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.